Endocrinology and Metabolism10.3803/enm.2020.8182021362374-387Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-AnalysisDeep Dutta, Anshita Agarwal, Indira Maisnam, Rajiv Singla, Deepak Khandelwal, Meha Sharma,,
Diabetes & Metabolic Syndrome: Clinical Research & Reviews10.1016/j.dsx.2022.1024692022164102469Safety and efficacy of once weekly dipeptidyl-peptidase-4 inhibitor trelagliptin in type-2 diabetes: A meta-analysisDeep Dutta, Ritin Mohindra, Vineet Surana, Meha Sharma,
Drug, Healthcare and Patient Safety10.2147/dhps.s627020107Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacyJennifer Green
Diabetes, Obesity and Metabolism10.1111/dom.120602013156523-530Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin aloneE. J. Rhee, W. Y. Lee, K. W. Min, V. K. Shivane, A. R. Sosale, H. C. Jang, C. H. Chung, I. S. Nam-Goong, J. A. Kim, S. W. Kim,,
Value in Health10.1016/s1098-3015(11)72061-72010137A283PDB3 EFFICACY AND SAFETY OF DIPEPTIDYL-PEPTIDASE 4 [DPP 4] INHIBITORS IN TYPE 2 DIABETES: META-ANALYSISH Park, YA Kim, KL Rascati,
Diabetes, Obesity and Metabolism10.1111/dom.120922013159810-818Efficacy, safety and dose-response relationship of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitusT. Kadowaki, K. Kondo,
Diabetic Medicine10.1111/j.1464-5491.2010.03181.x2011284464-469Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetesJ. Rosenstock, A. J. Lewin, P. Norwood, V. Somayaji, T. T. Nguyen, J. G. Teeter, S. L. Johnson, H. Dai, S. G. Terra,
Value in Health10.1016/j.jval.2012.03.9312012154A172PDB10 A Meta-Analysis of Efficacy and Safety of Dipeptidyl Peptidase-4 [Dpp-4] Inhibitors in Type 2 DiabetesH. Park, C. Park, Y. Kim, K.L. Rascati,
Annals of Pharmacotherapy10.1345/aph.1r041201246111453-1469Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes: Meta-AnalysisHaesuk Park, Chanhyun Park, Yoona Kim, Karen L Rascati,,
Diabetes Research and Clinical Practice10.1016/j.diabres.2016.03.011201611686-95Efficacy and safety of the addition of a dipeptidyl peptidase-4 inhibitor to insulin therapy in patients with type 2 diabetes: A systematic review and meta-analysisYeong Gi Kim, Se Hee Min, Seokyung Hahn, Tae Jung Oh, Kyong Soo Park, Young Min Cho,